V
Vivekanandhan Govindasamy
Publications - 3
Citations - 602
Vivekanandhan Govindasamy is an academic researcher. The author has contributed to research in topics: Virus & Context (language use). The author has an hindex of 3, co-authored 3 publications receiving 418 citations.
Papers
More filters
Journal ArticleDOI
COVID-19: A promising cure for the global panic.
Balachandar Vellingiri,Kaavya Jayaramayya,Mahalaxmi Iyer,Arul Narayanasamy,Vivekanandhan Govindasamy,Bupesh Giridharan,Singaravelu Ganesan,Anila Venugopal,Dhivya Venkatesan,Harsha Ganesan,Kamarajan Rajagopalan,Pattanathu K. S. M. Rahman,Ssang-Goo Cho,Nachimuthu Senthil Kumar,Mohana Devi Subramaniam +14 more
TL;DR: The structure of virus; varying symptoms among COVID-19, SARS, MERS and common flu; the probable mechanism behind the infection and its immune response; and traditional Indian medicinal plants as possible novel therapeutic approaches, exclusively targeting SARS-CoV-2 and its pathways are discussed.
Journal ArticleDOI
Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots.
Anila Venugopal,Harsha Ganesan,Suresh S. S. Raja,Vivekanandhan Govindasamy,Manimekalan Arunachalam,Arul Narayanasamy,Palanisamy Sivaprakash,Pattanathu K. S. M. Rahman,Abilash Valsala Gopalakrishnan,Zothan Siama,Balachandar Vellingiri +10 more
TL;DR: The use of nanofiber filters as a wastewater pre-treatment routine and up-gradation of existing wastewater evaluation and treatment system, to serve as a beneficial surveillance tool to identify possible hotspots in the early stages of any disease.
Journal ArticleDOI
Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
Pallab Kar,Vijay Kumar,Balachandar Vellingiri,Arnab Sen,Nishika Jaishee,Akash Anandraj,Himani Malhotra,Subires Bhattacharyya,Subhasish Mukhopadhyay,Masako Kinoshita,Vivekanandhan Govindasamy,Ayan Roy,Devashan Naidoo,Mohana Devi Subramaniam +13 more
TL;DR: The inhibitory potential of the phytochemicals from ethnomedicinally relevant Indian plants, including Justicia adhatoda, Ocimum sanctum and Swertia chirata, with reported antiviral activities against crucial SARS-CoV-2 proteins are estimated to be promising druggable targets for COVID-19 therapeutic research.